Stock Analysis of Artelo Biosciences Inc. WT (ARTLW) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code ARTLW
Close 0.0155
Change 0.0034 / 28.10 %
Volume 1000.00
Vol Change 500.00 / 100.00 %
IndustryOther
SectorOther
AIO Strength Index
Technical StrengthMild Bullish
Growth Index Low Growth Stock
Value Index Low Value Stock
Profitability Index Poor Profitability Stock
Stability Index No Significant Stability


Fundamental View of Artelo Biosciences Inc. WT


Highs/Lows of Artelo Biosciences Inc. WT
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week0.0121 28.10 % 1.54 % 0.01740.01210-May-2410-May-24
Two Week0.0193 19.69 % 3.42 % 0.01750.011903-May-2403-May-24
One Month0.0162 4.32 % 5.60 % 0.02350.011318-Apr-2418-Apr-24
Three Month0.0152 1.97 % 5.95 % 0.07210.01118-Mar-2412-Mar-24
Six Months0.02 22.50 % 17.48 % 0.14980.00512-Dec-2301-Dec-23
One year0.0785 80.25 % 27.52 % 0.210.00514-Jun-2301-Dec-23
Two year0.0642 75.86 % 29.70 % 0.420.00516-Aug-2201-Dec-23


Technical View of Artelo Biosciences Inc. WT






Charts of Artelo Biosciences Inc. WT


Returns of Artelo Biosciences Inc. WT with Peers
Period / StockARTLWVERBW
1 Week28.10%-47.30%
1 Mth-4.32%532.35%
3 Mth1.97%437.50%
6mth-22.50%82.20%
1 Year-80.25%7.50%
2 Year-75.86%-93.48%
5 Years--
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Artelo Biosciences Inc. WT with Peers
Ratio / StockARTLWVERBW
PE-0.0049-1.52
P/B0.003316.54
ROA-63.02-145.39
ROE-67.13-1091.69
Debt To Equity0.00210.709
Revenue0
%
9466.00 K
0.329 %
Net Income-9874.00 K
2.07 %
-35125.00 K
6.18 %


Technicals of Artelo Biosciences Inc. WT with Peers
Technical / StockARTLWVERBW-
ADX37.6065.83
CMF-0.216-0.167
MFI72.6071.04
RSI48.6445.94
MACD Abv SignalTrueFalse
Price Above 50 MAFalseTrue-
Price Above 200 MAFalseTrue-


About : Artelo Biosciences Inc


Address : 505 Lomas Santa Fe, Solana Beach, CA, United States, 92075
Tel : 858 925 7049
URL : https://www.artelobio.com
Code : ARTLW, Exchange : NASDAQ, Country : USA
Fiscal Year End : August
IPO date : 21_Jun_2019
Employee Count : 6

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. It's product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment anxiety, post-traumatic stress disorder, epilepsy, inflammatory bowel disease, and other potential indications; and ART26.12, a fatty acid binding protein 5 inhibitor for treating chemotherapy induced peripheral neuropathy, diabetic neuropathy, prostate cancer and breast cancer, pain, dermatologic conditions, and anxiety disorders. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.


Note : All Data Generated at the End of Trading Hours (EOD Data)